Novartis and Roche enjoy pharma-industry leading 2024 revenues. They also lead in total international patent volume. But Roche, with more oncology-specific patents for cancer treatment
Tag: cancer
“Patents Enable Investment” says Henry Hadad on Season Premiere of Understanding IP Matters
When it comes to IP rights, confusion reigns. Some people believe weaker IP systems that encourage uncertain patents result in lower drug prices and more
ipcloseup.com 